This could finally be the start of the drugmaker's comeback.
ALLEROD, Denmark, Jan 30 (Reuters) - A play examining the meteoric rise of Danish weight-loss drug giant Novo Nordisk will ...
Novo Nordisk A/S (NYSE:NVO) is among the most profitable healthcare stocks to buy. On January 26, BMO Capital lifted the ...
Thomas Rantzau, employee representative on the Board of Directors since 2018, has decided to pursue new opportunities outside Novo Nordisk A/S after 22 years of employment. Therefore, he steps down ...
Novo Nordisk A/S gains in GLP-1 obesity pills with strong U.S. marketing. Click for this NVO stock update and a preview of ...
Jan 20 (Reuters) - Danish drugmaker Novo Nordisk and Canada-based privately held Aspect Biosystems said on Tuesday they have ...
The past couple of years have been challenging for the company. But this could be the beginning of a new chapter.
Why economic leverage beats military pressure on Greenland, and how Denmark’s exposure through Novo Nordisk makes trade tools faster, quieter, and more effective.
Novo Nordisk GBS aims to expand advanced research in India, enhancing its Bengaluru hub's role in global R&D and clinical ...
Reimagining Weight Management with Digital Opinion Leaders, held between 27–28 January in Dubai. As the first summit of its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results